Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate |
2016-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2021-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-107454843-B |
titleOfInvention |
Pharmaceutical composition for treating cancer comprising microribonucleic acid as active ingredient |
abstract |
The present invention relates to a pharmaceutical composition for the treatment of cancer comprising at least one miRNA selected from miR-3670, miR-8078 and miR-4477a as an active ingredient. The pharmaceutical composition for treating cancer of the present invention has excellent effects of inhibiting proliferation of cancer cells and inducing destruction of cancer cells. Therefore, the pharmaceutical composition of the present invention can be effectively used as an anticancer agent. |
priorityDate |
2015-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |